Apellis Pharmaceuticals stock performance outpaced the broader market index on July 31, 2025.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Apellis Pharmaceuticals stock performance outpaced the broader market index on July 31, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Apellis Pharmaceuticals (United States)
company in Crestwood, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksApellis Pharmaceuticals (APLS) Reports Q2 Earnings: What Key Metrics Have to Say Apellis Pharmaceuticals, Inc. (APLS) reported $178.49 million in revenue for the quarter ended June 2025, representing